City

Shanghai (2)

Condition

Allogeneic Hematopoeitic Stem Cell Transplantation (2)

High Risk Acute Myeloid Leukemia (2)

Overall Status

Recruiting (2)

Sign in for free

Phase

phase 3 (2)

Sponsor

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (2)

Collaborator

Changhai Hospital (2)

Chengdu PLA General Hospital (2)

Fujian Medical University Union Hospital (2)

Tang-Du Hospital (2)

Tongji Hospital (2)

Wuhan Union Hospital, China (2)

Xiangya Hospital of Central South University (2)

Intervention

busulfan (2)

cladribine (2)

cytarabine (2)

fludarabine (2)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

allogeneic hematopoeitic stem cell transplantation

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

High Risk Acute Myeloid Leukemia, Allogeneic Hematopoeitic Stem Cell Transplantation Trial in Shanghai (Cladribine, Fludarabine,

Recruiting

High Risk Acute Myeloid Leukemia
Allogeneic Hematopoeitic Stem Cell Transplantation

Cladribine
+3 more

Shanghai, Shanghai, China

Shanghai general hospital, Shanghai Jiaotong university school o

Oct 10, 2021

High Risk Acute Myeloid Leukemia, Allogeneic Hematopoeitic Stem Cell Transplantation Trial in Shanghai (Cladribine, Fludarabine,

Recruiting

High Risk Acute Myeloid Leukemia
Allogeneic Hematopoeitic Stem Cell Transplantation

Cladribine
+3 more

Shanghai, Shanghai, China

Shanghai general hospital, Shanghai Jiaotong university school o

Oct 10, 2021